SAN DIEGO–(BUSINESS WIRE)–Aardvark Therapeutics, Inc. (Aardvark), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced the appointments of Roy D. Baynes, M.D., Ph.D., and Susan E. Graf, RPh, MBA to its Board of Directors. Dr. Baynes was previously Chief Medical Officer and head of clinical development at Merck. Ms. Graf is currently a senior advisor a

CAMBRIDGE, Mass.–(BUSINESS WIRE)– #AI–Prudentia Sciences Launches with $7M in Funding to Transform the Life Sciences Marketplace for Dealmaking

NASHVILLE, Tenn.–(BUSINESS WIRE)–Once again, Montecito Medical has been named as a “Key Influencer in Healthcare Real Estate.” The national recognition came from the editors of Real Estate Forum and GlobeSt. Partners, who publish an annual list of influencers in specific areas of real estate that include healthcare, retail, industrial and multifamily housing. This marks the seventh consecutive year that the publication has named Montecito or its leadership as Key Influencers in the medical re

MANASSAS, Va.–(BUSINESS WIRE)– #CancerResearch–ATCC has been awarded a five-year, IDIQ contract by NCI to provide lab services to support AMRVS with research and vaccine development.

SAN DIEGO–(BUSINESS WIRE)– #digitalpathology–XiFin, a leading provider of innovative healthcare revenue cycle management solutions that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, today previewed findings from its 2025 Pharmacy Transformation Outlook Survey, which highlights the growing role of pharmacists and the increasing interest in achieving operational efficiency through new technology and expanding pharmacy offerings via value-based care and spec

ORLANDO, Fla.–(BUSINESS WIRE)– #ClinicalResearch–The Heart & Kidney Health Screening offers no-cost Lp(a) testing as well as screenings for other related metabolism and kidney risks.

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Abdera Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable precision radiopharmaceuticals for cancer, today announced that Lori Lyons-Williams, president and chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. PT in San Francisco, CA. Ms. Lyons will detail the company’s

CHICAGO–(BUSINESS WIRE)–Press Ganey, the leading provider of experience measurement, data analytics, and insights for health systems and health plans, has released its latest research report, “Health Plan Member Experience in 2024.” This report highlights critical areas for improvement in member experience, drawing on regulatory, voice-of-the-customer, and Press Ganey’s patient experience data. The findings underscore the pressing need for health plans to address barriers to higher member sat

DENVER–(BUSINESS WIRE)–TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), TriSalus Life Sciences seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, announced today the publication of research titled, “Pressure Enabled Drug Delivery (PEDD) Significantly Increases Intraarterial Delivery of Embolic Microspheres to Liver Tumors in a Porcine Mode

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics (“BBOT” or the “Company”), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BBO-8520, an investigational oral therapy for the treatment of adult patients with previously treated, KRASG12C-mutated metastatic non-small cell lung cancer (NSCLC). BBO-8520 is designed to i